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Mass Spectrometry. All high-resolution mass spectra (HRMS) were recorded by the LMU Mass Spectrometry Service. HRMS were recorded on a MAT 90 (ESI) spectrometer from Thermo Finnigan GmbH.
UV-Vis Spectroscopy. UV-Vis spectra were recorded on a Varian Cary 50 Scan UV-Vis spectrometer using Helma SUPRASIL precision cuvettes (10 mm light path).
LCMS. LCMS was performed on an Agilent 1260 Infinity HPLC System, MS-Agilent 1100
Series, Type: 1946D, Model: SL, equipped with a Agilent Zorbax Eclipse Plus C18 (100 × 4.6 mm, particle size 3.5 micron) reverse phase column. Retention times (t R ) are given in minutes (min).
Synthetic Procedures Synthesis and characterisation of ({[5-chloro-2-nitro-4-(trifluoromethyl)phenyl]amino} methyl)phosphonic acid (3)
To a suspension of compound 2 (3.12 g, 12.0 mmol) in EtOH/H 2 O (100 mL, 1:1) at r.t. was added compound 1 (1.29 g, 11.6 mmol) and Na 2 CO 3 (1.32 g, 12.5 mmol). 1575, 1525, 1511, 1426, 1413, 1353, 1301, 1272, 1234, 1209, 1176, 1131, 1114, 1073, 1014, 946, 917, 877, 846, 742, 702 3361, 2985, 1621, 1579, 1530, 1435, 1354, 1317, 1302, 1243, 1205, 1157, 1126, 1049, 1024, 969, 945, 917, 897, 838, 781, 764, 702 δ 20.5; IR (thin film): 3355, 2981, 2931, 1720, 1625, 1609, 1575, 1532, 1486, 1427, 1346, 1305, 1268, 1235, 1153, 1122, 1048, 1019, 971, 794, 764, 735 3362, 2979, 2936, 1703, 1607, 1583, 1530, 1488, 1367, 1302, 1233, 1197, 1152, 1106, 1049, 1019, 973, 789 
Synthesis and characterisation of diethyl {[7-(3-aminophenyl)-2,3-dioxo-6-(trifluoro methyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonate (12)
To a solution of compound 9 (932 mg, 1.80 mmol) in THF (90 mL) and Et 3 N (1.28 g, 12.6 mmol, 1.76 mL) at r.t. was added ethyl chlorooxoacetate (11) (639 mg, 4.68 mmol, 0.52 mL) dropwise. The resulting mixture was stirred at r.t. for 20 h. After this time the reaction mixture was filtered and the filtrate was concentrated under reduced pressure. The resulting residue was dissolved in EtOH (60 mL) and a solution of HCl (60 mL,
was added. The mixture was heated to 120 °C for 2.5 h, cooled to r.t. and the ethanol was removed under reduced pressure. The resulting aqueous layer was washed with CH 2 Cl 2 (2 × 50 mL) and its pH was adjusted to 10-11 using a solution of Na 2 CO 3851, 3744, 3648, 3334, 2980, 1699, 1652, 1558, 1489, 1373, 1231, 1163, 1122, 1080, 1019, 
Synthesis and characterisation of diethyl {[7-(3-{(E)-[4-(dimethylamino)phenyl]diazenyl} phenyl)-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonate (15)
To a 2983, 2905, 1698, 1622, 1598, 1518, 1364, 1264, 1235, 1153, 1120, 1047, 1017, 945, 822, 733 3100, 2980, 2930, 1721, 1624, 1574, 1521, 1405, 1366, 1346, 1314, 1287, 1264, 1232, 1151, 1115, 1047, 1016, 971, 836, 764, 3364, 2978, 2930, 1703, 1584, 1511, 1431, 1403, 1391, 1366, 1312, 1232, 1150, 1103, 1048, 1017, 971, 897, 838, 805, 773 
phenyl)-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonate (16)
To a solution of compound 13 (38.0 mg, 0.0800 mmol) in MeOH (1.6 mL) at 0 °C was added conc. HCl (0.04 mL) dropwise. t-Butyl nitrite (17.0 mg, 0.160 mmol, 21 µL, 90% purity) was added dropwise and the resulting solution was stirred at 0 °C for 30 min. The diazonium salt was then added dropwise to a flask containing N,N-dimethylaniline (14) (11.0 mg, 0.0880 mmol, 11 µL) in MeOH (1.6 mL) and conc. HCl (0.04 mL) at 0 °C. The resulting solution was stirred at 0 °C for 2 h and then at r.t. for 2 h. The reaction was quenched with sat. aq.
NaHCO 3 (10 mL) and extracted with EtOAc (2 × 10 mL 3075, 2984, 2909, 1704, 1622, 1600, 1519, 1421, 1366, 1312, 1237, 1157, 1139, 1082, 1047, 1020, 846, 822 
Synthesis and characterisation of {[7-(4-{(E)-[4-(dimethylamino)phenyl]diazenyl}phenyl)-

2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid TFA salt (ShuBQX-2)
To a suspension of compound 16 (24.0 mg, 0.0400 mmol) in H 2 O (1 mL) at r. 7, 157.6, 154.9, 153.2, 152.7, 151.9, 142.6, 139.8, 134.0, 130.1, 128.9, 125.0, 124.9, 123.9 3063, 2950, 1682, 1671, 1620, 1594, 1543, 1367, 1350, 1274, 1241, 1207, 1169, 1137, 1123, 1108, 1074, 955, 937, 909, 894, 838, 824, 726 cm , 2981, 2931, 1723, 1633, 1577, 1541, 1425, 1355, 1339, 1301, 1251, 1213, 1153, 1112, 1048, 1022, 972 , 761 cm , 2981, 2931, 1713, 1622, 1597, 1537, 1489, 1453, 1392, 1369, 1335, 1300, 1245, 1198, 1150, 1094, 1048, 1023, 970, 867, 824 
Synthesis and characterisation of diethyl (E)-((2,3-dioxo-7-(phenyldiazenyl)-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl)methyl)phosphonate (S1) and ({2,3-dioxo-7-[(E)-phenyldiazenyl]-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl}methyl)phosphonic acid (ShuBQX-3)
To a solution of compound 19 (132 mg, 0.248 mmol) in THF (11 mL) and Et 3 N (174 mg, 0, 155.3, 153.8, 145.8, 133.2, 131.1, 130.4, 129.0, 125.9 , 3073, 2961, 1694, 1619, 1393, 1358, 1298, 1269, 1241, 1136, 1062, 1019, 933, 771, 732, 687 153.8, 145.8, 133.4, 130.9, 130.5, 129.2, 126.1, 124.4, 121.8, 115.5, 105.0, 64.8, 64.7, 40.04 (d, J = 156.9 Hz), 39.3, 16.7, 16.7 1619, 1508, 1387, 1297, 1269, 1241, 1207, 1137, 1048, 1022, 981, 772 Figure S1 . UV-Vis absorption spectra of ShuBQX-1, ShuBQX-2 and ShuBQX-3. Solutions of ShuBQX-1 (50 µM in DMSO), ShuBQX-2 (50 µM in DMSO), ShuBQX-3 (50 µM in DMSO, left and 50 µM in Ringer buffer, right) were placed in a 1 mL quartz cuvette (10 mm diameter). A light-fibre cable connected to a Till Photonics Polychrome 5000 monochromator was placed in the cuvette until it penetrated the surface of the solution. Illumination was screened from wavelengths 380-600 nm in 20 nm steps (ShuBQX-1 and ShuBQX-2) and 340-500 nm in 20 nm steps (ShuBQX-3) going from higher to lower wavelengths. Every wavelength was applied for 5 min before a UV-Vis spectrum was recorded. Illumination conditions that afforded the highest trans-isomer and cis-isomer enrichment are shown in Figure S1 . Figure S2 . Action spectra of ShuBQX-1 and ShuBQX-2. Action spectra of ShuBQX-1 (5 µM, left) and ShuBQX-2 (5 µM, right) in the presence of glutamate (300 μM) under illumination with green light (580 nm) and varying wavelengths. 
HEK293T Cell Electrophysiology
HEK293T cells were incubated in dulbecco ś minimal essential medium + 10% FBS and split at 80 to 90% confluency. For detachment, growth medium was removed, cells were washed with calcium free PBS buffer and cells were treated with trypsin solution at 37 °C for 2 min.
Detached cells were diluted with growth medium and singularised by pipetting. For transfection, acid-etched coverslips were coated with poly-L-lysin and placed in a 24-well plate. 40 000 cells were added to each well in 500 µL standard growth medium. DNA (per coverslip: 350 ng GluA1-L497Y and 50 ng YFP) was mixed with 1 µL polyplus jetprime in 50 µL jetprime buffer. After standing at room temperature for 10-15 min, the DNA-mix was added to the cells shortly after seeding them into the abovementioned 24-well plate. After 3-5 hours the medium was exchanged for standard growth medium. Cells were used for electrophysiological recordings 24 hours post transfection.
Whole-cell patch clamp experiments were performed using a standard electrophysiology setup equipped with a HEKA Patch Clamp EPC10 USB amplifier and PatchMaster software (HEKA Electronik). Micropipettes were generated from a Science Products GB200-F-8P with filament pipettes using a vertical puller. Resistance varied between 3-7 MΩ. The extracellular solution contained in mM: 138 NaCl, 1.5 KCl, 2.5 CaCl 2 , 1.2 MgCl 2 , 10 glucose and 5 HEPES (NaOH to pH 7.4). The intracellular solution contained in mM: 140 K-gluconate, 5 NaCl, 15 KCl, 5.0 MgATP, 0.5 Na 2 ATP and 12.5 HEPES (pH 7.3). The holding potential for voltage clamp experiments was −60 mV. The antagonists ShuBQX-1, ShuBQX-2 and ShuBQX-3 were diluted into the extracellular solution from 100 mM DMSO stock solutions. Glutamate was diluted into the extracellular solution from a 100 mM H 2 O stock solution. Illumination during electrophysiology experiments was provided by a Poly V, FEI monochromator.
Brain Slice Electrophysiology
All animal procedures were performed in accordance with the guidelines of the Regierung Oberbayern. Horizontal slices were prepared from C57Bl6JRj mice (postnatal day 12-14).
Following decapitation, the brain was rapidly removed and transferred to an ice-cold saline solution composed of (in mM) 87 NaCl, 75 sucrose, 25 NaHCO 3 , 2.5 KCl, 1.25 NaH 2 PO 4 , 0.5 CaCl 2 , 7 MgCl 2 , 25 glucose saturated with carbogen (95% O 2 /5% CO 2 ). Slices (300 µm thick) -1 with nuclease-free water.
All animal procedures were performed in accordance with the Tierschutzgesetz (TierSchG) and the TierschutzVersuchstierverordnung (TierSchVersV). Frog oocytes of stages V or VI were obtained by surgical removal of the ovaries of a X. laevis frog previously anesthetized with ethyl 3-aminobenzoate methanesulfonate (2.3 g·L -1 ; Sigma). The ovaries were cut and under constant shaking incubated with 300 U·mL -1 (10 mg· mL -1 ) collagenase type I
